Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction

• Anja Möricke,
• Carmelo Rizzari,
• Julia Alten,
• Andishe Attarbaschi,
• Rita Beier,
• Andrea Biondi,
• Birgit Burkhardt,
• Nicole Bodmer,
• Joachim Boos,
• Gunnar Cario,
• Valentino Conter,
• Christian Flotho,
• Andreas Kulozik,
• Claudia Lanvers-Kaminsky,
• Georg Mann,
• Felix Niggli,
• Daniela Silvestri,
• Arend von Stackelberg,
• Martin Stanulla,
• Maria-Grazia Valsecchi,
• Martin Schrappe,
• Martin Zimmermann

Affiliations

Anja Möricke

1 Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany

Carmelo Rizzari

2 Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy

Julia Alten

1 Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany

Andishe Attarbaschi

3 Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Medical University of Vienna, Austria

Rita Beier

5 Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany

Andrea Biondi

2 Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy

Birgit Burkhardt

6 Department of Paediatric Hematology and Oncology, University Hospital Muenster, Germany

Nicole Bodmer

7 University Children’s Hospital, Zurich, Switzerland

Joachim Boos

6 Department of Paediatric Hematology and Oncology, University Hospital Muenster, Germany

Gunnar Cario

1 Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany

Valentino Conter

2 Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy

Christian Flotho

8 Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Germany

Andreas Kulozik

9 Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany

Claudia Lanvers-Kaminsky

6 Department of Paediatric Hematology and Oncology, University Hospital Muenster, Germany

Georg Mann

4 St. Anna Kinderspital and Children’s Cancer Research Institute, Vienna, Austria

Felix Niggli

7 University Children’s Hospital, Zurich, Switzerland

Daniela Silvestri

10 Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy

Arend von Stackelberg

11 Pediatric Hematology and Oncology, Charité Medical Center, Humboldt University, Berlin, Germany

Martin Stanulla

5 Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany

Maria-Grazia Valsecchi

10 Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy

Martin Schrappe

1 Department of Pediatrics I, Pediatric Hematology/Oncology, ALL-BFM Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany

Martin Zimmermann

5 Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany